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INTRODUCTION
R etinoblastoma (RB) is the most common malignant tumor in children. In order to protect vision and avoid enucleation, chemotherapy is currently considered to be an important treatment for RB. Chemotherapeutic can induce tumor regression and allow for focal treatments, such as cryotherapy and photocoagulation [1] [2] [3] [4] . It is reported that fewer eyes were lost because of the use of ophthalmic artery chemosurgery and intravitreal melphalan in RB [5] . And intraarterial chemotherapy (IAC) provides significantly superior control for solid tumor, subretinal seeds, and vitreous seeds [6] . Presently, vincristine, etoposide, and carboplatin (VEC) have been using in clinical of eyeball preserving conservative management in RB [7] . Nevertheless, drug resistance and relapses remain a major problem. Chemoresistance may be tumor inherent, or occur during administration of chemotherapy drugs. Multidrug resistance (MDR) has been associated with elevated expression of some particular proteins. P-glycoprotein (P-gp) was considered as one of the important MDR proteins. It was known to cause an increased efflux of cytotoxic drugs from the tumor cells and had the ability to mediate MDR [8] [9] . Glutathione-S-transferase (GST), a class of phase II xenobiotic metabolism enzymes, playing an important role in cellular detoxification [10] . In addition, glutathione-S-transferase π (GSTπ) might also participate in oncogenesis, tumor progression, metabolism and drug resistance [11] . Lung resistance protein (LRP), the major component of complex ribonucleoprotein particles called "vaults," like P-gp, is believed to be link to the MDR [3] . In the recent decades, extensive researches have been done on MDR in RB, and several MDR associated proteins were involved. But the available data in regard to primary drug resistance is scanty and controversial. And the expression of GSTπ in RB has hardly any mentioned. From literatures and clinical we found chemotherapy drug resistance phenomenon was common in RB. So we speculated that RB might have different degrees of natural drug resistance genes expression. [12] . The degree of choroidal invasion was classified in five subgroups: I, no invasion; II, minimal invasion (tumor cells destroying Bruch's membrane without invading the choroid to any depth); III, massive invasion (any choroidal involvement that is not minimal); IV, intrascleral invasion; and V, extrascleral invasion. ON tumor invasion was classified in four subgroups: I, no invasion; II, prelaminar invasion; III, postlaminar invasion; and IV, invasion through the resection line and/or subarachnoid space [12] . Immunohistochemistry Four-micrometer-thick specimen sections were deparaffinized with xylene and rehydrated through graded ethanol washes. Endogenous peroxidase activity was blocked by incubation in 3% hydrogen peroxide for 10min at room temperature. Slides were washed with phosphate-buffered saline (PBS) 3 times. The slides were soaked in citric acid buffer (pH 6.0), and was heated by microwave for 8min to expose the antigen. Nonspecific protein binding was blocked using 1% bovine serum albumin (BSA)/Tris-buffered saline (TBS, pH 7.6) solution for 30min. Next, sections were incubated with the mouse antihuman monoclonal antibody for GSTπ, P-gp and LRP (Dako, Denmark) at room temperature in a humidified chamber for 1h. Then, sections were washed and incubated with biotinylated rabbit anti-mouse antibody (Dako, Denmark) for 30min. Immunostaining visualization was developed with diaminobenzidine (DAB, Dako, Denmark) and counterstained with hematoxylin. Immunoreactivity Scoring Two ophthalmic pathologists independently assessed the expression of GSTπ, P-gp and LRP by microscopy, and the final interpretation was based on agreeing assessments. GSTπ, P-gp and LRP expressions were graded semi quantitatively as negative (-, <10%), weakly positive (+, 10%-25%), positive (++, 25%-50%) and strong positive (+++, >50%) of viable tumor cells stained positive. Statistical Analysis Statistical analysis was performed using Spearman correlation coefficient analysis and χ 2 test. P value of less than 0.05 was considered statistically significant. All statistical analyses were using statistical-analysis software (SPSS 16.0, USA).
RESULTS
The mean age of patients was 20mo, and the group was composed of 59.52% boys (n=25) and 40.48% girls (n=17 
respectively).
Immunohistochemistry revealed granular cytoplasmic expression of GSTπ (Figure 1 ), granular cellular membrane or (and) cytoplasmic expression of P-gp, and cytoplasmic expression of LRP ( Figure 2 ). LRP expressed in 14 (33.33%) of 42 tumors with a cytoplasmic pattern. the other two proteins showed no evident correlations to the differentiation of the tumor (P>0.05, respectively; Figure 3 ). There was no statistically significant relationship between the expressions of P-gp, LRP or GSTπ and choroidal invasion, ON invasion (P>0.05, respectively). DISCUSSION RB is the most common ocular malignant tumor in little children. In order to preserve vision and avoid enucleation, chemotherapy is currently an important modality for the treatment of RB. However, local tumor recurrence remains a major problem due to drug resistance. MDR has been linked to elevated expression of particular proteins, such as multidrug resistance proteins (MRP), LRP, breast cancer resistant protein (BCRP), and so on. Our results showed that drug resistance associated proteins of GSTπ, P-gp and LRP differently expressed in RB treated with primary enucleation. GSTπ was positive in most (92.86%) of 42 tumors. GST-π, the cytosolic detoxification protein, is generally in synergy with multidrug resistance proteins-1 (MRP1) to confer resistance to the chemotherapeutic agents, especially platinum drugs [8, [13] [14] . Expression of the lung GST-π, LRP and MRP1 were all significantly upregulated in sphere-derived cells [15] . However, GSTπ has been scantly involved in RB drug resistance research so far. We found higher GSTπ expression rate in well differentiated tumors (100%) than in poor differentiated tumors (90.91%). This suggests that most untreated RB intrinsically express GSTπ. And drug resistance more likely happens in differentiated RB. P-gp was vital in a series of RB cell lines and samples from RB patients who showed clinically resistance to chemotherapy [13] . We observed higher P-gp expression in WD tumors than PD tumors but without statistical significance. Insufficient case count might be the cause of the failure to show statistical significance. P-gp is more frequently expressed in RB enucleated after chemotherapy [12] . We found that P-gp is intrinsically expressed in 78.57% of our RB tumors. Our result was similar to other reports [16] . However, It was observed that P-gp was expressed only 26.7% in RB treated with primary enucleation [17] .
There was no statistically significant difference between the two groups in regard to the degree of ocular choroidal invasion and ON invasion. However, 92.86% RB expressed GSTπ, which suggested that GSTπ might be a new target in chemotherapeutic treatment of RB. "+++", "++" and "+" are considered as positive staining, "-" are considered as negative staining; PD: Poorly differentiated; WD: Well differentiated. Interestingly, we observed that the expression of LRP (33.33%), another important MDR associated protein [18] , which was rarely expressed in our research. The result was obviously different from other researches. While, other researches considered that the overexpression of LRP could predict the sensitivity of cancer patients to chemotherapy and prognosis, and the expression of LRP was associated with primary resistance to vincristine, doxorubicin and platinum compounds [19] . We presumed that LRP might not work well as a resistance index in RB before chemotherapy, and it might only be some relationship with secondary drug resistance. RB intrinsically expresses GSTπ, P-gp and LRP. The expression of the three resistance proteins may not be induced by chemotherapy, and there is nothing relationship with the degree of tumor invasion. The high expression of GSTπ, P-gp and LRP may lead to chemotherapy failure. And only GSTπ expression was related to tumor differentiation. The results could explain the chemotherapy drug resistance phenomenon of RB in clinical. In addition, GSTπ protein may be the novel and effective target of chemotherapy in RB. These findings might have important implications for the treatment of RB patients.
